What's Happening?
Mel Robbins, a well-known author and speaker, discusses the often-overlooked genitourinary syndrome of menopause (GSM) and its impact on women's health. In a recent podcast, Robbins interviewed Dr. Rachel Rubin, who explained that GSM can occur during
various hormonal changes, not just menopause. Symptoms include urinary frequency, pelvic pain, and recurrent UTIs. Dr. Rubin emphasized the effectiveness of vaginal estrogen in reducing these symptoms, yet many women remain unaware of this treatment. Robbins shared her personal experiences with UTIs and highlighted the need for greater awareness and access to GSM treatments.
Why It's Important?
The discussion sheds light on GSM, a condition affecting many women but often underdiagnosed and undertreated. Raising awareness about GSM and its treatment options, such as vaginal estrogen, can significantly improve women's quality of life. This information is crucial for women experiencing hormonal changes at any life stage, as untreated GSM can lead to severe health complications. By advocating for better education and access to treatments, Robbins aims to empower women to take control of their health and seek appropriate care.
What's Next?
Efforts to increase awareness of GSM and its treatments may involve educational campaigns and advocacy for over-the-counter access to vaginal estrogen. Healthcare providers could play a key role in informing patients about GSM and encouraging proactive management of symptoms. As awareness grows, more women may seek treatment, leading to improved health outcomes and reduced healthcare costs associated with untreated GSM.
